End-of-day quote
Shenzhen S.E.
06:00:00 2024-07-16 pm EDT
|
5-day change
|
1st Jan Change
|
31.55
CNY
|
-1.96%
|
|
-1.19%
|
-10.42%
|
Fiscal Period: December |
2019
|
2020
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
8,042
|
14,326
|
8,652
|
10,909
|
9,772
|
-
|
-
|
Enterprise Value (EV)
1 |
8,042
|
14,326
|
8,652
|
10,909
|
9,772
|
9,772
|
9,772
|
P/E ratio
|
38.1
x
|
52.2
x
|
163
x
|
65.4
x
|
48.5
x
|
35.1
x
|
27.2
x
|
Yield
|
0.43%
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
12.5
x
|
20.6
x
|
-
|
9
x
|
6.07
x
|
4.8
x
|
3.74
x
|
EV / Revenue
|
12.5
x
|
20.6
x
|
-
|
9
x
|
6.07
x
|
4.8
x
|
3.74
x
|
EV / EBITDA
|
27.6
x
|
-
|
-
|
41.6
x
|
28.8
x
|
21.9
x
|
17.3
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
5.35
x
|
-
|
-
|
2.63
x
|
2.3
x
|
2.22
x
|
2.12
x
|
Nbr of stocks (in thousands)
|
290,649
|
290,649
|
311,332
|
309,730
|
309,730
|
-
|
-
|
Reference price
2 |
27.67
|
49.29
|
27.79
|
35.22
|
31.55
|
31.55
|
31.55
|
Announcement Date
|
2/27/20
|
4/7/21
|
4/26/23
|
3/11/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
641
|
693.9
|
-
|
1,212
|
1,610
|
2,036
|
2,610
|
EBITDA
1 |
291.7
|
-
|
-
|
262
|
339
|
447
|
564
|
EBIT
1 |
263.9
|
330.8
|
-
|
189.1
|
229
|
317
|
409
|
Operating Margin
|
41.17%
|
47.68%
|
-
|
15.6%
|
14.22%
|
15.57%
|
15.67%
|
Earnings before Tax (EBT)
1 |
263.1
|
329.6
|
-
|
186.5
|
226
|
314
|
407
|
Net income
1 |
210.3
|
274.3
|
53.23
|
166.8
|
202
|
281
|
364
|
Net margin
|
32.81%
|
39.54%
|
-
|
13.76%
|
12.55%
|
13.8%
|
13.95%
|
EPS
2 |
0.7265
|
0.9439
|
0.1707
|
0.5389
|
0.6500
|
0.9000
|
1.160
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
0.1200
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/27/20
|
4/7/21
|
4/26/23
|
3/11/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
15.3%
|
7.39%
|
-
|
3.74%
|
4.7%
|
6.3%
|
7.8%
|
ROA (Net income/ Total Assets)
|
12.4%
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
1,692
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
5.170
|
-
|
-
|
13.40
|
13.70
|
14.20
|
14.90
|
Cash Flow per Share
2 |
0.1300
|
-
|
-
|
0.4800
|
0.8000
|
0.7500
|
0.9700
|
Capex
1 |
44.8
|
-
|
-
|
207
|
35
|
125
|
50
|
Capex / Sales
|
6.99%
|
-
|
-
|
17.04%
|
2.17%
|
6.14%
|
1.92%
|
Announcement Date
|
2/27/20
|
4/7/21
|
4/26/23
|
3/11/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -10.42% | 1.37B | | +2.88% | 102B | | -5.63% | 62.47B | | +85.24% | 52.55B | | +7.15% | 35.34B | | +3.66% | 31.83B | | +7.16% | 19.21B | | +16.25% | 17.58B | | +8.88% | 13.89B | | +75.12% | 12.76B |
Other Commodity Chemicals
|